Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 15, 2022.
Article Versions
- You are currently viewing a Latest version of this article (November 15, 2022 - 04:00).
- latest version (February 1, 2023 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Kanon Jatuworapruk,
- Panchalee Satpanich,
- Philip C. Robinson and
- Rebecca Grainger
- Faculty of Medicine, Thammasat University, Pathumthani, Thailand; Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand; Department of Rheumatology, Royal Brisbane and Women's Hospital, Metro North Hospital & Health Service; Faculty of Medicine, University of Queensland, Queensland, Australia; Department of Medicine, University of Otago, Wellington, New Zealand.
Source of support: The study was supported by clinical research grant from the Faculty of Medicine, Thammasat University, grant number 1-02/2565.
Conflict of interest: PR reports personal fees from Abbvie, Atom Biosciences, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Kukdong, Novartis, UCB, Roche, Pfizer; meeting attendance support from BMS, Pfizer and UCB and grant funding from Janssen, Novartis, Pfizer and UCB Pharma. RG reports personal fees from AbbVie, Janssen, Cornerstones, Novartis; meeting attendance support from Pfizer. KJ and PS have nothing to disclose.
Corresponding author: Kanon Jatuworapruk, Department of Medicine, Faculty of Medicine, Thammasat University, 99/209 Paholyotin Road, Khlong Luang, Pathumthani, 12120 Thailand. Email: kanon@tu.ac.th